These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2908595)

  • 41. Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.
    Xu B; Song X; Yip NC; Xiao P; Zhang Y; Wang W; Zhou S
    Hematology; 2010 Apr; 15(2):74-80. PubMed ID: 20423567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone marrow transplantation for childhood Ki-1 lymphoma.
    Chakravarti V; Kamani NR; Bayever E; Lange B; Herzog P; Sanders JE; August CS
    J Clin Oncol; 1990 Apr; 8(4):657-60. PubMed ID: 2156024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy.
    Maddox AM; Johnston DA; Barlogie B; Youness E; Keating M; Freireich EJ
    J Clin Oncol; 1985 Jun; 3(6):799-808. PubMed ID: 4009216
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Common acute lymphoblastic leukemia characterized by four different DNA stemlines with heterogeneity in RNA content, antigen expression and sensitivity to chemotherapy.
    Redner A; Grabowski E; Al-Katib A; Andreeff M
    Leuk Res; 1986; 10(6):671-6. PubMed ID: 3458978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Minimal residual disease in leukemia and lymphoma: biological significance and clinical applications].
    Gavosto F; Saglìo G; Foà R
    Haematologica; 1989 Oct; 74(5 Suppl):85-95. PubMed ID: 2512235
    [No Abstract]   [Full Text] [Related]  

  • 46. DNA, RNA, and protein content in adult acute myeloid leukemia: effects of cytostatic drugs in vivo.
    Wolowiec D; Ffrench M; Tigaud JD; Treille-Ritouet D; Archimbaud E; Bryon PA
    Leukemia; 1988 Aug; 2(8):534-9. PubMed ID: 3166079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purging by dye-mediated photosensitization.
    Porcellini A; Manna M; Marchetti-Rossi MT; Sparaventi G
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():188-9. PubMed ID: 2653501
    [No Abstract]   [Full Text] [Related]  

  • 48. Preliminary clinical trial of autologous bone marrow transplantation after in vitro monoclonal antibody and complement treatments in null cell-type acute lymphocytic leukemia.
    Morishima Y; Sao H; Ueda R; Morishita Y; Murase T; Kodera Y; Ohno R; Tahara T; Yoshikawa S; Kato Y
    Jpn J Cancer Res; 1985 Dec; 76(12):1222-9. PubMed ID: 3937834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Flow cytometry in the determination of DNA aneuploidy in patients with acute leukemias].
    Shmarov DA; Kuchma IuM; Miterev GIu; Kozinets GI
    Ter Arkh; 1996; 68(7):11-4. PubMed ID: 8928064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autologous bone marrow transplantation in acute leukemia.
    Gorin NC
    J Natl Cancer Inst; 1986 Jun; 76(6):1281-7. PubMed ID: 2940400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Elmaagacli AH; Beelen DW; Schaefer UW
    Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Double immunoenzymatic APAAP staining for the detection of leukemia-associated immunophenotypes.
    Sucić M; Boban D; Marković-Glamocak M; Uzarević B; Zadro R; Petrovecki M; Ries S; Gjadrov K; Golemović M; Stavljenić-Rukavina A; Labar B; Batinić D
    J Hematother Stem Cell Res; 1999 Dec; 8(6):635-43. PubMed ID: 10645771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of minimal residual disease in acute leukemia.
    Seshadri R
    Blood; 1995 Sep; 86(6):2452. PubMed ID: 7662995
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrow.
    Douay L
    Rev Fr Transfus Immunohematol; 1985 Nov; 28(5):427-36. PubMed ID: 3912921
    [No Abstract]   [Full Text] [Related]  

  • 55. Perspectives of monoclonal antibodies in the acute leukaemias.
    Hervé P; Wijdenes J; Racadot E
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():198-201. PubMed ID: 2653503
    [No Abstract]   [Full Text] [Related]  

  • 56. Estimations of BCR-ABL/ABL transcripts by quantitative PCR in chronic myeloid leukaemia after allogeneic bone marrow transplantation and donor lymphocyte infusion.
    Otazú IB; Tavares Rde C; Hassan R; Zalcberg I; Tabak DG; Seuánez HN
    Leuk Res; 2002 Feb; 26(2):129-41. PubMed ID: 11755463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroblastoma cells circulate in peripheral blood.
    Lanino E; Melodia A; Casalaro A; Cornaglia-Ferraris P
    Pediatr Hematol Oncol; 1989; 6(2):193-5. PubMed ID: 2702074
    [No Abstract]   [Full Text] [Related]  

  • 58. Minimal residual disease after bone marrow transplant for chronic myeloid leukaemia detected by the polymerase chain reaction.
    Cross NC; Feng L; Bungey J; Goldman JM
    Leuk Lymphoma; 1993; 11 Suppl 1():39-43. PubMed ID: 8251914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].
    Musto P; Carotenuto M
    Haematologica; 1991 Jun; 76 Suppl 3():169-72. PubMed ID: 1684343
    [No Abstract]   [Full Text] [Related]  

  • 60. Combined cell sorting and FISH for detection of minimal residual disease in bone marrow of children with acute leukemia or solid tumors.
    Sainati L; Spinelli M; Leszl A; Cocito MG; Stella M; Basso G
    Eur J Histochem; 1997; 41 Suppl 2():167-8. PubMed ID: 9859833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.